Vasopressors for the treatment of septic shock: Systematic review and meta-analysis.
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: International guidelines recommend dopamine or norepinephrine as first-line vasopressor agents in septic shock. Phenylephrine, epinephrine, vasopressin and terlipressin are considered second-line agents. Our objective was to assess the evidence for the efficiency and safety of all vasopressors in septic shock. METHODS: Systematic review and meta-analysis. We searched electronic database of MEDLINE, CENTRAL, LILACS and conference proceedings up to June 2014. We included randomized controlled trials comparing different vasopressors for the treatment of adult patients with septic shock. Primary outcome was all-cause mortality. Other clinical and hemodynamic measurements were extracted as secondary outcomes. Risk ratios (RR) and mean differences with 95% confidence intervals (CI) were pooled. RESULTS: Thirty-two trials (3,544 patients) were included. Compared to dopamine (866 patients, 450 events), norepinephrine (832 patients, 376 events) was associated with decreased all-cause mortality, RR 0.89 (95% CI 0.81-0.98), corresponding to an absolute risk reduction of 11% and number needed to treat of 9. Norepinephrine was associated with lower risk for major adverse events and cardiac arrhythmias compared to dopamine. No other mortality benefit was demonstrated for the comparisons of norepinephrine to epinephrine, phenylephrine and vasopressin / terlipressin. Hemodynamic data were similar between the different vasopressors, with some advantage for norepinephrine in central venous pressure, urinary output and blood lactate levels. CONCLUSIONS: Evidence suggests a survival benefit, better hemodynamic profile and reduced adverse events rate for norepinephrine over dopamine. Norepinephrine should be regarded as the first line vasopressor in the treatment of septic shock.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the absence of septic shock or fungemia, some implanted tunneled catheter infections may be treated effectively with prolonged antimicrobial therapy if removal of the catheter is not practical (273).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [273]
Experimental — accuracy not yet measuredIn the citing paper
“In a systematic review and meta-analysis of 11 RCTs, norepinephrine resulted in a lower mortality (RR 0.89; 95% CI 0.81–0.98) and lower risk of arrhythmias (RR 0.48; 95% CI 0.40–0.58) compared with dopamine [347].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [347]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743 · cited 1×
“5 ml/kg/hr within 6 hours of initiation of therapy [5].”
BackgroundEstimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503 · cited 1×
“Septic shock accounts for about 9% of admissions, and is the most common cause of death in intensive care units (ICUs) [1,2].”
BackgroundSurviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,321
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,018 · cited 2×
“The Surviving Sepsis Campaign recommends norepinephrine or dopamine as the first-choice vasopressor agent followed by epinephrine in patients who respond poorly to dopamine or norepinephrine [7,8].”
BackgroundA randomized trial of protocol-based care for early septic shock.
The ProCESS Investigators (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401602 · Cited by 2,414 · cited 6×
“The concept of early goal directed therapy was challenged recently in a large RCT [43], in which no mortality benefit with protocol based resuscitation was observed compared with usual care.”
BackgroundInfluentialComparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940 · cited 5×
“triple blinded [15], 8 trials were double blinded [13, 24, 26, 27, 30–32, 36], 2 were single blinded [20, 34] and the others were open-labeled or not stated.”
BackgroundResultInfluentialVasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Research works printed but not linked: 3
- H Chen, 2012, Comparisom of the effect and complication between dopaimne and norepinephrine on treatment of the septic shock, Jiangxi Medical Journal, 47, 565
- K High, 2008, Impact of Dopamine and norepinephrine on renal perfusion in patients with septic shock, Journal of Hebei Medicine, 30, 1188
- Y Zhuangyu, 2011, Affect of norepinephrine and dopamine on infectious tissue oxygen metabolism and hemodynamics in patients with shock, Shandong Medicine Journal, 51, 93
Cited by
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
“However, a recent systematic review and meta-analysis that included 11 randomized trials (n =1,710) comparing norepinephrine to dopamine does not support the routine use of dopamine in the management of septic shock (264).”
BackgroundSurviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002198 · Cited by 1,228
Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05878-6 · Cited by 606
Sepsis: The evolution in definition, pathophysiology, and management
Gyawali, B., Ramakrishna, K., & Dhamoon, A. S. (2019) · SAGE Open Medicine · doi:10.1177/2050312119835043 · Cited by 512
GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance
Luan, H. H., Wang, A., Hilliard, B. K., Carvalho, F., Rosen, C. E., Ahasic, A. M., Herzog, E. L., Kang, I., Pisani, M. A., Yu, S., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.033 · Cited by 527
“Finally, because the addition of exogenous catecholamines, and in particular noradrenaline, is the mainstay of the management of septic shock (Avni et al., 2015; Oba and Lone, 2014), and GDF15 appeared to be controlling hepatic noradrenaline outflow, we asked whether injection of GDF15 alone could improve survival out…”
Sepsis and Septic Shock – Basics of diagnosis, pathophysiology and clinical decision making
Font, M. D., Thyagarajan, B., & Khanna, A. K. (2020) · Medical Clinics of North America · doi:10.1016/j.mcna.2020.02.011 · Cited by 420
“Specifically, in a septic patient with hypotension and with evidence of cardiomyopathy and associated right heart dysfunction, epinephrine may be added for inotropic benefit and if cardiac output is insufficient to maintain perfusion.(64) Vasopressin is a non–catecholamine molecule that directly acts on V1 and V2 rece…”
BackgroundMartin, L., Derwall, M., Al Zoubi, S., Zechendorf, E., Reuter, D. A., Thiemermann, C., & Schuerholz, T. (2019) · Chest · doi:10.1016/j.chest.2018.08.1037 · Cited by 360
“98) compared with dopamine.(73) Therefore, the Society of Critical Care Medicine guidelines(69) suggest the use of dopamine instead of norepinephrine only when a patient”
BackgroundDopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 308
Vasopressors for hypotensive shock
Gamper, G., Havel, C., Arrich, J., Losert, H., Pace, N. L., Müllner, M., & Herkner, H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003709.pub4 · Cited by 239
Vasopressor therapy in critically ill patients with shock
Russell, J. A. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05801-z · Cited by 226
Acute Liver Failure Guidelines
Shingina, A., Mukhtar, N., Wakim-Fleming, J., Alqahtani, S., Wong, R. J., Limketkai, B. N., Larson, A. M., & Grant, L. (2023) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002340 · Cited by 220
“Norepinephrine is the preferred vasopressor due to its association with survival benefit and decreased adverse outcomes (73,81).”
BackgroundSepsis and septic shock: Guideline-based management
Dugar, S., Choudhary, C., & Duggal, A. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.18143 · Cited by 229
Current use of vasopressors in septic shock
Scheeren, T. W. L., Bakker, J., De Backer, D., Annane, D., Asfar, P., Boerma, E. C., Cecconi, M., Dubin, A., Dünser, M. W., Duranteau, J., et al. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0498-7 · Cited by 192
Karvellas, C. J., Bajaj, J. S., Kamath, P. S., Napolitano, L. M., O’Leary, J. G., Solà, E., Subramanian, R., Wong, F. S.-H., & Asrani, S. K. (2023) · Hepatology · doi:10.1097/hep.0000000000000671 · Cited by 194
Update of Sepsis in the Intensive Care Unit
Genga, K. R., & Russell, J. A. (2017) · Journal of Innate Immunity · doi:10.1159/000477419 · Cited by 158
Nanchal, R., Subramanian, R., Karvellas, C. J., Hollenberg, S. M., Peppard, W. J., Singbartl, K., Truwit, J., Al-Khafaji, A. H., Killian, A. J., Alquraini, M., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004192 · Cited by 153
Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis
Stolk, R. F., van der Poll, T., Angus, D. C., van der Hoeven, J. G., Pickkers, P., & Kox, M. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0862cp · Cited by 148
“In addition, a recent meta-analysis failed to show a survival benefit for norepinephrine over phenylephrine (56).”
Dopaminergic Regulation of Innate Immunity: a Review
Pinoli, M., Marino, F., & Cosentino, M. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9749-2 · Cited by 136
Bellomo, R., Wunderink, R. G., Szerlip, H. M., English, S. W., Busse, L. W., Deane, A. M., Khanna, A. K., McCurdy, M. T., Ostermann, M., Young, P. J., et al. (2020) · Critical Care · doi:10.1186/s13054-020-2733-x · Cited by 131
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge
Deutsche Sepsis Gesellschaft e., V., Brunkhorst, F. M., Weigand, M. A., Pletz, M. W., Gastmeier, P., Lemmen, S., Meier‐Hellmann, A., Ragaller, M., Weyland, A., Marx, G., et al. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00685-0 · Cited by 148
Yealy, D. M., Mohr, N. M., Shapiro, N. I., Venkatesh, A. K., Jones, A. E., & Self, W. H. (2021) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2021.02.006 · Cited by 136
“87,88 Adding vasopressin (0.03 to 0.04 U/min) is a reasonable approach to reduce norepinephrine requirements and decrease complications, especially at high doses.”
BackgroundInfluentialNishida, O., Ogura, H., Egi, M., Fujishima, S., Hayashi, Y., Iba, T., Imaizumi, H., Inoue, S., Kakihana, Y., Kotani, J., et al. (2018) · Journal of Intensive Care · doi:10.1186/s40560-017-0270-8 · Cited by 118
“[147] was adopted as evidence as it had the highest quality.”
MethodHernández-Tejedor, A., Peñuelas, Ó., Sirgo, G., Llompart-Pou, J. A., Herrejon, E. P., Estella, Á., Cabanes, M. P. F., Alcalá-Llorente, M. A., Galleymore, P. R., Azuara, B. O., et al. (2017) · Medicina Intensiva · doi:10.1016/j.medin.2017.03.004 · Cited by 114
Vasopressor Therapy in the Intensive Care Unit
Russell, J. A., Gordon, A. C., Williams, M. D., Boyd, J. H., Walley, K. R., & Kissoon, N. “. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1710320 · Cited by 110
Challenges in the management of septic shock: a narrative review
Backer, D. D., Cecconi, M., Lipman, J., Machado, F. R., Myatra, S. N., Ostermann, M., Perner, A., Teboul, J., Vincent, J., & Walley, K. R. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05544-x · Cited by 102
Sepsis and Septic Shock Strategies
Armstrong, B., Betzold, R., & May, A. K. (2017) · Surgical Clinics of North America · doi:10.1016/j.suc.2017.07.003 · Cited by 100
Boyanova, L. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.01.003 · Cited by 89
“Norepinephrine and dopamine have been recommended as first-line vasopressor drugs in septic shock, and epinephrine has been included in the second-line agents [12,13].”
BackgroundSociety for Maternal-Fetal Medicine Consult Series #67: Maternal sepsis
Shields, A. D., Plante, L. A., Pacheco, L. D., & Louis, J. M. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.05.019 · Cited by 92
Nishida, O., Ogura, H., Egi, M., Fujishima, S., Hayashi, Y., Iba, T., Imaizumi, H., Inoue, S., Kakihana, Y., Kotani, J., et al. (2018) · Acute Medicine & Surgery · doi:10.1002/ams2.322 · Cited by 85
Timing of vasoactive agents and corticosteroid initiation in septic shock
Ammar, M. A., Ammar, A. A., Wieruszewski, P. M., Bissell, B. D., Long, M. T., Albert, L., Khanna, A. K., & Sacha, G. L. (2022) · Annals of Intensive Care · doi:10.1186/s13613-022-01021-9 · Cited by 78
“hypotension, the evidence has been contrary, with signals of increased mortality in a meta-analysis compared to norepinephrine [17].”
ResultThe initial resuscitation of septic shock
Cinel, I., Kasapoglu, U. S., Gul, F., & Dellinger, R. P. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.02.004 · Cited by 69
Methylene blue administration in patients with refractory distributive shock – a retrospective study
Pořízka, M., Kopecký, P., Dvorakova, H., Kunstýř, J., Lipš, M., Michálek, P., & Balík, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-58828-4 · Cited by 73
Influences of stress hormones on microbial infections
Sarkodie, E. K., Zhou, S., Baidoo, S. A., & Chu, W. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.04.013 · Cited by 77
Sartelli, M., Tascini, C., Coccolini, F., Dellai, F., Ansaloni, L., Antonelli, M. M., Bartoletti, M., Bassetti, M., Boncagni, F., Carlini, M., et al. (2024) · World Journal of Emergency Surgery · doi:10.1186/s13017-024-00551-w · Cited by 77
“Some evidence showed that early administration of vasopres-sors significantly increases shock control by 6 h [53, 54].”
BackgroundSepsis With Preexisting Heart Failure: Management of Confounding Clinical Features
Jones, T. W., Smith, S. E., Tuyl, J. S. V., & Sikora, A. N. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066620928299 · Cited by 72
“58).(104) The data observed a lower relative heart rate (HR) of 19 beats per minute when comparing NE to dopamine, which may minimize increases in myocardial oxygen demand.”
BackgroundEscobar, M. F., Echavarría, M. P., Zambrano, M., Ramos, I. J. A., & Kusanovic, J. P. (2020) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2020.100149 · Cited by 70
Vasopressors and Inotropes in Sepsis
Stratton, L., Berlin, D., & Arbo, J. E. (2016) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2016.09.005 · Cited by 66
“than dopamine in the treatment of septic shock, with an absolute risk reduction of 11% in mortality compared with dopamine in a recent systematic review.(34) Dopamine also doubled the risk of cardiac arrhythmias in this analysis and in an earlier metaanalysis by De Backer and colleagues,(35) who reported a relative ri…”
ResultMøller, M. H., Claudius, C., Junttila, E., Haney, M., Oscarsson‐Tibblin, A., Haavind, A., & Perner, A. (2016) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12780 · Cited by 61
“Of note, another recently published systematic review by Avni et al.14 was considered but excluded, as a result of methodological limitations, including no published/registered protocol, inclusion of several high risk of bias trials, no continuity correction in the no event trials (sensitivity analysis), and no assess…”
ResultHam, K. R., Boldt, D. W., McCurdy, M. T., Busse, L. W., Favory, R., Gong, M. N., Khanna, A. K., Chock, S., Zeng, F., Chawla, L. S., et al. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0536-5 · Cited by 57
Intensive care management of acute-on-chronic liver failure
Bernal, W. E., Karvellas, C. J., Saliba, F., Saner, F. H., & Meersseman, P. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.10.024 · Cited by 58
Management of post-cardiac arrest syndrome
Kang, Y. (2019) · Acute and Critical Care · doi:10.4266/acc.2019.00654 · Cited by 53
“[16] recommended norepine phrine as the first-line vasopressor because norepinephrine was associated with decreased mortality, lower risk for major adverse events, and cardiac arrhythmias compared to dopamine.”
BackgroundManagement of Sepsis and Septic Shock: What Have We Learned in the Last Two Decades?
Kamath, S., Altaq, H. H., & Abdo, T. (2023) · Microorganisms · doi:10.3390/microorganisms11092231 · Cited by 68
“Furthermore, in a 2015 systemic review and meta-analysis of 11 randomized controlled trials comparing norepinephrine and dopamine, norepinephrine had a better hemodynamic profile, lower risk for adverse events and arrhythmia, and overall lower mortality (RR 0.89; 95% CI 0.81–0.98) [81].”
InfluentialVasoactive-Inotropic Score as an Early Predictor of Mortality in Adult Patients with Sepsis
Song, J., Cho, H., Park, D. W., Moon, S., Kim, J. Y., Ahn, S., Lee, S.-G., & Park, J.-H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030495 · Cited by 53
“It is the first-line vasopressor in septic shock and associated with fewer adverse effects and lower mortality than dopamine [25,26].”
BackgroundBezinover, D. S., Mukhtar, A. M., Wagener, G., Wray, C. L., Blasi, A., Kronish, K., Zerillo, J., Tomescu, D. R., Pustavoitau, A., Gitman, M., et al. (2021) · Transplantation · doi:10.1097/tp.0000000000003642 · Cited by 49
“There is no difference in mortality, but there are fewer adverse reactions with NE than with epinephrine,(87-89) and no difference in mortality between NE and either vasopressin or terlipressin.(85,87,88) Rapid hemodynamic response to exogenous vasopressin administration has been demonstrated in LT patients who typica…”
BackgroundChow, J. H., Abuelkasem, E., Sankova, S. K., Henderson, R. A., Mazzeffi, M. A., & Tanaka, K. A. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004343 · Cited by 48
Management of liver failure in general intensive care unit
Paugam‐Burtz, C., Levesque, É., Louvet, A., Thabut, D., Amathieu, R., Bureau, C., Camus, C., Chanques, G., Faure, S., Ferrandière, M., et al. (2019) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2019.06.014 · Cited by 54
“There is no specific literature to guide the type of fluids to use or the choice of vasopressor agents [30,31].”
BackgroundLat, I., Coopersmith, C. M., & Backer, D. D. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004864 · Cited by 49
Machine-learning-derived sepsis bundle of care
Kalimouttou, A., Lerner, I., Cheurfa, C., Jannot, A., & Pirracchio, R. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06928-2 · Cited by 50
“For instance, the recommendation on vaso-pressin use overlaps with the recommendation on norepinephrine [41] and the one on the mean arterial blood pressure target.”
BackgroundCheng, L., Yan, J., Han, S., Chen, Q., Chen, M., Jiang, H., & Lü, J. (2019) · Critical Care · doi:10.1186/s13054-019-2427-4 · Cited by 51
Jaramillo, R. P. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.07.026 · Cited by 48
Bitton, E., Zimmerman, S. F., Azevedo, L. C. P., Benhamou, D., Cecconi, M., Waele, J. J. D., Lipman, J., Martín‐Loeches, I., Pirracchio, R., Scheeren, T., et al. (2021) · Journal of Critical Care · doi:10.1016/j.jcrc.2021.11.016 · Cited by 45
Nanchal, R. S., Subramanian, R., Karvellas, C. J., Hollenberg, S. M., Peppard, W., Singbartl, K., Truwit, J. D., Al-Khafaji, A. H., Killian, A. J., Alquraini, M., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004193 · Cited by 43
“Despite the paucity of studies directly related to liver failure, indirect evidence from trials in other distributive states such as septic shock suggest norepinephrine is superior compared with dopamine is reversing hypotension as well as associated with lower mortality and risk of arrhythmias (4).”
BackgroundPharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review
MacKenzie, M., & Hall, R. (2016) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-016-0748-1 · Cited by 47
“Catecholamines are frequently used in the ICU to support patients with hemodynamic deterioration due to a variety of shock states.(126) Polymorphisms of the b2-adrenergic receptor (b2AR) have been described.”
MethodHemodynamic dysfunction in neonatal sepsis
Kharrat, A., & Jain, A. (2021) · Pediatric Research · doi:10.1038/s41390-021-01855-2 · Cited by 48
Review: sepsis guidelines and core measure bundles
Desposito, L., & Bascara, C. J. (2024) · Postgraduate Medicine · doi:10.1080/00325481.2024.2388021 · Cited by 45
“A systematic review and meta-analysis of 11 RCTs demonstrated a lower risk of mortality and arrhythmias with norepinephrine compared to dopamine [55].”
Meng, L., Sun, Y., Zhao, X., Meng, D. M., Liu, Z., Adams, D. C., McDonagh, D. L., & Rasmussen, M. (2023) · Anaesthesia · doi:10.1111/anae.16172 · Cited by 38
“Such work should focus on patients with conditions such as traumatic brain injury [104, 105], spinal cord injury [106], ischaemic stroke [107], septic shock [108 – 110] and those undergoing anaesthesia [13, 28, 29, 111].”
BackgroundVasoactive Agent Use in Septic Shock: Beyond First‐Line Recommendations
Sacha, G. L., Bauer, S. R., & Lat, I. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2220 · Cited by 43
de Molina, F. J. G., Vidal, F. G., Estella, Á., Valdeolmillos, P. M., Ortega, J. F. F., López, J. C., Villares, P. V. P., Sanz, M. A. B., de Haro, C., Riera, J. A. S.-I., et al. (2018) · Medicina Intensiva · doi:10.1016/j.medin.2018.04.001 · Cited by 42
Lat, I., Coopersmith, C. M., Backer, D. D., & Coopersmith, C. M. (2021) · Intensive Care Medicine Experimental · doi:10.1186/s40635-021-00369-9 · Cited by 48
Кirov, М. Y., Владимирович, К. В., Николаевич, П. Д., Щеголев, А. В., Babaev, M. A., Belotserkovskiy, B. Z., Bykov, A. O., Gritsan, A. I., Кулабухов, В. В., Kulikov, A. V., et al. (2023) · Annals of critical care · doi:10.21320/1818-474x-2023-4-7-42 · Cited by 44
Liu, W., Cui, F., Li, H., Wang, S., Zhuo, B., & Wang, S. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.128669 · Cited by 35
Quantitative Assessment of Blood Lactate in Shock: Measure of Hypoxia or Beneficial Energy Source
Levitt, D. G., Levitt, J. E., & Levitt, M. D. (2020) · BioMed Research International · doi:10.1155/2020/2608318 · Cited by 41
“, dopamine, norepinephrine, epinephrine, and vasopressin) [104], which no doubt alter the pathophysiology.”
BackgroundNorepinephrine in Septic Shock: A Systematic Review and Meta-analysis
bin Ruslan, M. R., Baharuddin, K. A., Norhayati, M. N., Yazid, M., Noh, A. Y. M., & Rahman, A. (2021) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2020.10.47825 · Cited by 48
Ortiz, F. J. G. D. M., Vidal, F. G., García, A., Valdeolmillos, P. M., Ortega, J. F. F., López, J. C., Villares, P. V. P., Sanz, M. A. B., de Haro, C., Riera, J. A. S.-I., et al. (2018) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2018.04.007 · Cited by 33
Infection, Sepsis and the Inflammatory Response: Mechanisms and Therapy
Lonsdale, D., Shah, R. V., & Lipman, J. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.588863 · Cited by 35
“Superiority of norepinephrine over dopamine has been demonstrated in systematic reviews, both in terms of survival outcome and reduced adverse effects (58, 59).”
BackgroundS3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M. W., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01317-1 · Cited by 47
Nedel, W. L., Rech, T. H., Ribeiro, R. A., Pellegrini, J. A. S., & Moraes, R. B. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003471 · Cited by 37
Deutsche Sepsis Gesellschaft e., V., Brunkhorst, F. M., Weigand, M. A., Pletz, M. W., Gastmeier, P., Lemmen, S., Meier‐Hellmann, A., Ragaller, M., Weyland, A., Marx, G., et al. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00671-6 · Cited by 37
Zonneveld, L. E. E. C., van Wijk, R. J., Olgers, T. J., Bouma, H. R., & ter Maaten, J. C. (2022) · European Journal of Emergency Medicine · doi:10.1097/mej.0000000000000924 · Cited by 32
Expert consensus on blood pressure management in critically ill patients
Yu, Y., Gong, Y., Hu, B., Ouyang, B., Pan, A., Liu, J., Liu, F., Shang, X., Yang, X., Tu, G.-W., et al. (2023) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2023.06.001 · Cited by 37
“[25 , 26] Although dopamine β1 activity imroves cardiac function in patients with cardiac dysfunction, the igher incidence of arrhythmias limits its use.”
BackgroundEmergency medicine updates: Management of sepsis and septic shock
Long, B., & Gottlieb, M. A. (2025) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2025.01.054 · Cited by 34
Hemodynamic support in septic shock
García-de-Acilu, M., Mesquida, J., Gruartmoner, G., & Ferrer, R. (2021) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000959 · Cited by 30
“com high-quality evidence is scarce regarding a more significant benefit of one vasopressor over another [48], noradrenaline has been associated with decreased mortality [49].”
BackgroundSymmetrical peripheral gangrene in sepsis after treatment with inotropes
Jiang, J.-L., Tseng, L.-W., & Chang, H.-R. (2017) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_25_17 · Cited by 29
“Evidence has shown that norepinephrine should be regarded as the first-line vasopressor when treating septic shock [24].”
BackgroundZhang, Y., Zhou, Y., Li, W., Lyons, V., Johnson, A., Venable, A., Griswold, J., & Pappas, D. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b05305 · Cited by 33
Vasoactive agents for the treatment of sepsis
Zhang, Z., & Chen, K. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.08.58 · Cited by 31
“That means nine patients need to be treated to prevent one additional death (19).”
BackgroundMethodResultHiggins, A. M., Brooker, J., Mackie, M., Cooper, D. J., & Harris, A. (2020) · Journal of Intensive Care · doi:10.1186/s40560-019-0412-2 · Cited by 31
An Update on Pharmacologic Management of Neonatal Hypotension: When, Why, and Which Medication
Agakidou, E., Chatziioannidis, I., Kontou, A., Stathopoulou, T., Chotas, W., & Sarafidis, K. (2024) · Children · doi:10.3390/children11040490 · Cited by 27
“Based on these data, studies in neonates suggest NE as a first-line agent in septic shock [54,68,70,71,132], which should be implemented quickly to prevent the deterioration of cardiovascular function [218,220].”
BackgroundPractice guidance for the use of terlipressin for liver cirrhosis–related complications
Qi, X., Bai, Z., Zhu, Q., Cheng, G., Chen, Y., Dang, X., Ding, H., Han, J., Han, L., He, Y., et al. (2022) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221098253 · Cited by 26
Colling, K. P., Banton, K. L., & Beilman, G. J. (2018) · Surgical Infections · doi:10.1089/sur.2017.255 · Cited by 29
Risk factors and treatment of refractory anaphylaxis - a review of case reports
Francuzik, W., Dölle-Bierke, S., & Worm, M. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2018.1450140 · Cited by 25
“mortality and adverse events than epinephrine or norepinephrine [55].”
BackgroundNissimov, S., Joye, S., Kharrat, A., Zhu, F., Ripstein, G., Baczynski, M., Choudhury, J., Jasani, B., Deshpande, P., Ye, X. Y., et al. (2022) · European Journal of Pediatrics · doi:10.1007/s00431-022-04758-4 · Cited by 25
Meng, L., Sun, Y., Zhao, X., Rasmussen, M., Altarshan, Y., Meng, D. M., Liu, Z., Adams, D. C., & McDonagh, D. L. (2024) · Anaesthesia · doi:10.1111/anae.16313 · Cited by 22
Asher, E., Karameh, H., Nassar, H., Yosefy, C., Marmor, D. B., Perel, N., Taha, L., Tabi, M., Braver, O., Shuvy, M., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175734 · Cited by 23
“Similar to our analysis, studies evaluating the administration of vasopressor drugs in critically ill patients via peripheral venous access reported a low overall risk for local complications (4–7%) without significant morbidity [15,34,35].”
ResultVasopressin in Pediatric Critical Care
Choong, K. L. M. (2016) · Journal of Pediatric Intensive Care · doi:10.1055/s-0036-1583282 · Cited by 21
Circulatory shock in adults in emergency department
Pannu, A. K. (2023) · Turkish Journal of Emergency Medicine · doi:10.4103/2452-2473.367400 · Cited by 21
“Studies have found that dopamine use increases the risk of arrhythmia and overall mortality in patients with cardiogenic and septic shock.[76,81,82] Septic shock may cause a “relative vasopressin deficiency” state.”
BackgroundEpinephrine vs Norepinephrine as Initial Treatment in Children With Septic Shock
Eisenberg, M. A., Georgette, N., Baker, A. H., Priebe, G. P., & Monuteaux, M. C. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.4720 · Cited by 21
Wentowski, C. C., Mewada, N., & Nielsen, N. D. (2018) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2018.11.009 · Cited by 29
Neonatal septic shock, a focus on first line interventions.
Spaggiari, V., Passini, E., Crestani, S., Roversi, M. F., Bedetti, L., Rossi, K., Lucaccioni, L., Baraldi, C., Muttini, E. D. C., Lugli, L., et al. (2022) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v93i3.12577 · Cited by 25
Chen, C., Pang, L., Wang, Y., Wen, T., Yu, W., Yue, X., Rong, Y., & Liao, W. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.09.134 · Cited by 21
Guanabenz Prevents d-Galactosamine/Lipopolysaccharide-Induced Liver Damage and Mortality
Perego, J., Bourbon, C., Chasson, L., Laprie, C., Spinelli, L., Camosseto, V., Gatti, E., & Pierre, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00679 · Cited by 20
Haemodynamic management of septic shock
Kotani, Y., Ryan, N., Udy, A. A., & Fujii, T. (2024) · Burns & Trauma · doi:10.1093/burnst/tkae081 · Cited by 22
“Nora-drenaline has demonstrated superiority over dopamine in terms of efficacy and safety, including lower rates of arrhythmias and mortality [33, 97].”
Safe Use of Vasopressin and Angiotensin II for Patients with Circulatory Shock
Bauer, S. R., Sacha, G. L., & Lam, S. W. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2147 · Cited by 18
Hiemstra, B., Koster, G., Wetterslev, J., Gluud, C. N., Jakobsen, J. C., Scheeren, T., Keus, F., & van der Horst, I. C. C. (2018) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.13294 · Cited by 18
Vasodilatory shock in the ICU and the role of angiotensin II
Wakefield, B. J., Sacha, G. L., & Khanna, A. K. (2018) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000517 · Cited by 23
Yao, R.-Q., Xia, D., Wang, L., Wu, G., Zhu, Y., Zhao, H., Liu, Q., Xia, Z., Ren, C., & Yao, Y.-M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00563 · Cited by 20
Wedn, A. M., El‐Gowilly, S. M., & El‐Mas, M. M. (2020) · Inflammation Research · doi:10.1007/s00011-019-01309-w · Cited by 17
Early management of adult sepsis and septic shock: Korean clinical practice guidelines
Park, C., Ku, N. S., Park, D. W., Park, J. H., Ha, T. S., Kim, D., Park, S. Y., Chang, Y., Jo, K.-W., Baek, M. S., et al. (2024) · Acute and Critical Care · doi:10.4266/acc.2024.00920 · Cited by 21
Metadata
- Authors
- Avni, T., Lador, A., Lev, S., Leibovici, L., Paul, M., & Grossman, A.
- Affiliations
- Tel Aviv University (IL)
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Avni, Tomer
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-08-03
- Volume
- 10
- Issue
- 8
- Pages
- e0129305
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4523170
- OpenAlex
- W1630391490
- Cited by
- 293
- References
- 48
- Citations by year
- 2026: 19 · 2025: 24 · 2024: 33 · 2023: 26 · 2022: 29 · 2021: 37 · 2020: 30 · 2019: 34 · 2018: 29 · 2017: 17 · 2016: 11 · 2015: 3
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Health Sciences › Medicine › Surgery › Abdominal Surgery and Complications
- Keywords
- septic shock, vasopressors, norepinephrine, dopamine, phenylephrine, epinephrine, vasopressin, terlipressin, all-cause mortality, hemodynamic outcomes, cardiac arrhythmias, blood lactate
- MeSH terms
- Terlipressin, Epinephrine, Hemodynamics, Humans, Lypressin, Norepinephrine, Phenylephrine, Shock, Septic, Vasoconstrictor Agents, Vasopressins, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.